GB0812913D0 - Therapeutic compounds and their use - Google Patents
Therapeutic compounds and their useInfo
- Publication number
- GB0812913D0 GB0812913D0 GBGB0812913.2A GB0812913A GB0812913D0 GB 0812913 D0 GB0812913 D0 GB 0812913D0 GB 0812913 A GB0812913 A GB 0812913A GB 0812913 D0 GB0812913 D0 GB 0812913D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic compounds
- therapeutic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0812913.2A GB0812913D0 (en) | 2008-07-15 | 2008-07-15 | Therapeutic compounds and their use |
| PCT/GB2009/001786 WO2010007389A1 (en) | 2008-07-15 | 2009-07-15 | 5 -amidothiazole derivatives and their use as checkpoint kinase inhibitors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0812913.2A GB0812913D0 (en) | 2008-07-15 | 2008-07-15 | Therapeutic compounds and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0812913D0 true GB0812913D0 (en) | 2008-08-20 |
Family
ID=39722297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0812913.2A Ceased GB0812913D0 (en) | 2008-07-15 | 2008-07-15 | Therapeutic compounds and their use |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0812913D0 (en) |
| WO (1) | WO2010007389A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102924400A (en) * | 2012-12-03 | 2013-02-13 | 湖南大学 | N-acyl-4-tertiary butyl-5-benzyl thiazole-2-amine as well as preparation method and application thereof |
| CN103601697B (en) * | 2012-12-03 | 2015-03-25 | 湖南大学 | 4-tertiary butyl-5-(2-nitroethyl)-2-acylamino thiazole and preparation method and application thereof |
| CN111440127B (en) * | 2019-01-17 | 2022-07-26 | 青岛农业大学 | Thiazole amide compound and preparation and application thereof |
| WO2021225980A1 (en) * | 2020-05-04 | 2021-11-11 | Dna-Seq, Inc. | Methods and systems for determination of an effective therapeutic regimen and drug discovery |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006135604A2 (en) * | 2005-06-09 | 2006-12-21 | Merck & Co., Inc. | Inhibitors of checkpoint kinases |
-
2008
- 2008-07-15 GB GBGB0812913.2A patent/GB0812913D0/en not_active Ceased
-
2009
- 2009-07-15 WO PCT/GB2009/001786 patent/WO2010007389A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010007389A1 (en) | 2010-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249941A0 (en) | Spiro-oxindole compounds and their use as therapeutic agents | |
| GB0803018D0 (en) | Therapeutic compounds and their use | |
| GB0719803D0 (en) | Therapeutic compounds and their use | |
| GB0804685D0 (en) | Therapeutic compounds and their use | |
| GB0719644D0 (en) | Therapeutic compounds and their use | |
| GB0807609D0 (en) | Therapeutic compounds and their use | |
| GB0818241D0 (en) | Compounds and their use | |
| EP2300011A4 (en) | Therapeutic methods and compounds | |
| GB0724251D0 (en) | Therapeutic compounds and their use | |
| GB0722680D0 (en) | Therapeutic compounds and their use | |
| EP2268281A4 (en) | Thienopyrroles and pyrrolothiazoles as new therapeutic agents | |
| GB0817207D0 (en) | therapeutic apsac compounds and their use | |
| ZA201201287B (en) | Therapeutic aryl-amido-aryl compounds and their use | |
| GB0817208D0 (en) | Therapeutic apsap compounds and their use | |
| GB0812913D0 (en) | Therapeutic compounds and their use | |
| EP2231163A4 (en) | Compounds and therapeutic use thereof | |
| GB0801319D0 (en) | Compounds and their use | |
| GB0802128D0 (en) | Therapeutic compounds and their use | |
| GB0808690D0 (en) | Therapeutic use | |
| GB0815134D0 (en) | Therapeutic compounds and their use | |
| GB0705517D0 (en) | Therapeutic compounds and their use | |
| GB0821539D0 (en) | Therapeutic compounds and their use | |
| GB0913300D0 (en) | Therapeutic compounds and their use | |
| GB0800489D0 (en) | Therapeutic use | |
| GB0800487D0 (en) | Therapeutic use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |